Graftys SA-医療機器分野:企業M&A・提携分析

◆英語タイトル:Graftys SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011692
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products find application in bone reconstructive and trauma surgery; fracture repair, complex fractures, tibial osteotomy and joint arthroplasty, among others. It works in partnership with research institutions in France for the development of its product pipeline. The company’s research platform focuses on the development of orthopedic, trauma, spine and dental devices for various indications. The company has a presence in France and the US. Graftys is headquartered in Aix-en-Provence, France.

Graftys SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Graftys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Graftys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Graftys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Graftys SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Graftys SA, Medical Equipment, Deal Details 10
Venture Financing 10
Graftys Secures US$5.3 Million In Third Venture Financing Round 10
Partnerships 11
Arthrex Enters Into Co-Development Agreement With Graftys 11
Smith & Nephew Orthopaedics Enters Into Distribution Agreement With Graftys 12
Graftys SA – Key Competitors 13
Graftys SA – Key Employees 14
Graftys SA – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Mar 31, 2016: GRAFTYS strengthens its management and operations 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Graftys SA, Medical Equipment, Key Facts 2
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Graftys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Graftys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Graftys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Graftys SA, Deals By Market, 2011 to YTD 2017 8
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Graftys Secures US$5.3 Million In Third Venture Financing Round 10
Arthrex Enters Into Co-Development Agreement With Graftys 11
Smith & Nephew Orthopaedics Enters Into Distribution Agreement With Graftys 12
Graftys SA, Key Competitors 13
Graftys SA, Key Employees 14

★海外企業調査レポート[Graftys SA-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aplus Financial Co., Ltd.の企業概要及び財務/SWOT分析
    Aplus Financial Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quart …
  • LiDCO Group Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LiDCO Group Plc Mergers and Acq …
  • PetSmart, Inc.:企業の戦略・SWOT・財務分析
    PetSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PetSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Herstal SA:企業の戦略・SWOT・財務分析
    SummaryHerstal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • Fifth Street Finance Corp.:企業の戦略・SWOT・財務分析
    SummaryFifth Street Finance Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Wavefront Technology Solutions Inc. (WEE):企業財務及び戦略的SWOT分析
    Summary Wavefront Technology Solutions Inc. (Wavefront), formerly known as Wavefront Energy & Environmental Services Inc. is an oil and gas company that offers technology solutions. The company designs solutions for oil well stimulation, secondary oil recovery and environmental groundwater remediati …
  • Grupo Ferrer Internacional SA:企業の戦略・SWOT・財務分析
    SummaryGrupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Safe Orthopaedics SA (SAFOR)-医療機器分野:企業M&A・提携分析
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical equipment company that manufactures and markets minimally invasive devices for spinal surgery. The company’s product portfolio includes implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws …
  • Ignyta, Inc. (RXDX)(製薬・医療分野):企業M&A動向
    Summary Ignyta, Inc. (Ignyta), formerly NexDx, Inc., is a biotechnology company. It discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnosti …
  • Apexigen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company t hat focuses on discovery and development of antibody-based drugs for the treatment of cancer.The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell r …
  • Nikkiso Co., Ltd. (6376):企業のM&A・提携動向(医療機器分野)
    Summary Nikkiso Co., Ltd. (Nikkiso) is a diversified company, which develops, manufactures and markets medical equipment and industrial instruments. Nikkiso classifies its products into five categories: pumps, sampling systems and chemical feed systems; particle size characterization; equipment for …
  • Pristine Sun LLC:企業のM&A・提携動向(発電分野)
    Summary Pristine Sun LLC (Pristine Sun) is a full service renewable energy company that provides independent power generation, engineering, procurement, and construction, small utility-scale solar PV power plants development, mid-stage pipeline development, project financing, and project consulting …
  • BenQ Materials Corp. (8215):企業財務及び戦略的SWOT分析
    Summary BenQ Materials Corp. (BenQ Materials) is a technology company that manufactures optical storage products. The company manufactures and distributes optical media and polarizer products. It offers products through the divisions such as optical film, porous membrane and healthcare product. The …
  • United Energy Group Limited (467):企業の財務及び戦略的SWOT分析
    Summary United Energy Group Limited (UEG) is an investment holding company that participates in development of energy reserves. The company invests and operates oil, natural gas and other energy related businesses. Its activities include merger and acquisition of oil and natural gas assets, exploita …
  • Demand Media, Inc.:企業のM&A・提携・投資分析
    Demand Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Demand Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • McRae Industries, Inc.:戦略・SWOT・企業財務分析
    McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kymab Ltd:企業のM&A・提携動向(医療分野)
    Summary Kymab Ltd (Kymab) is a biopharmaceutical company that discovers and develops fully human monoclonal antibody drugs. The company offers pipepline of assets in three therapeutic areas such as immuno-oncology, immunology and opportunistic. Its products pipeline includes KY1003-Anti PD-L1, KY100 …
  • Proteomics International Laboratories Ltd (PIQ):製品パイプライン分析
    Summary Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based tech …
  • SeaRainbow Holding Corp (000503):企業財務及び戦略的SWOT分析
    Summary SeaRainbow Holding Corp (SeaRainbow) formerly Hainan Chemical Fiber Industry Corp. Ltd, is a chemical company that provides medical e-commerce and e-transaction services to medical and pharmaceutical industries. The company offers agency service to pharmaceutical manufacturers. SeaRainbow al …
  • Zodiac Aerospace SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zodiac Aerospace SA Mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆